References
- FitzmauriceCDickerDPainAThe global burden of cancer 2013JAMA Oncol20151450526181261
- LinJCisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinomaN Engl J Med1999340151154116110202166
- MorrisMEifelPJLuJPelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancerN Engl J Med1999340151137114310202164
- PetersWStockRMonkBConcurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervixJ Clin Oncol20001881606161310764420
- MalfetanoJConcurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancerN Engl J Med199934015114410202165
- WhitneyCWSauseWBundyBNRandomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group studyJ Clin Oncol19991751339134810334517
- LancianoRCalkinsABundyBNRandomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group studyJ Clin Oncol200523338289829516230678
- PetrelliFDeSARaspagliesiFLorussoDBarniSRadiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysisGynecol Oncol2014134116617124793000
- HuYCaiZQSuXYConcurrent weekly cisplatin versus triweekly cisplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis resultAsian Pac J Cancer Prev20121394301430423167332
- ChenXZouHLiHWeekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of cervical cancer: a meta-analysisInt J Gynecol Cancer2016272344349
- RyuSYLeeWMKimKRandomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancerInt J Radiat Oncol Biol Phys2011814577581
- KinjyoYNagaiYToitaTConcurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous cell carcinoma of the cervix: a retrospective analysis from a single institutionBr J Radiol20179010762017024128707541
- WellsGASheaBJO’ConnellDThe Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysisAppl Eng Agric2014186727734
- EinsteinMHNovetskyAPGargMSurvival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancerCancer201010914853
- NagyVMOrdeanuCCozaOAlinCRTrailaATodorNRandomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-upInt J Gynecol Cancer20122291538154423070071
- PreetyJFareedKAmitAComparative study of weekly versus three weekly cisplatin in advanced cases of carcinoma cervix alone with radiotherapyJournal of Evolution of Medical and Dental Sciences20154881531315320
- KumarPSharmaKSinghDPWeekly verses tri-weekly concurrent cisplatin with radiotherapy in the treatment of cervical cancer: a study comparing efficacy and toxicitySRMS Journal of Medical Sciences2017126672
- PandaNBagSSamantaraySRandomised clinical trial of weekly vs. triweekly cisplatin based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancerInt J Med Clin Res20175042006020064
- MittalSChauhanAKaurPComparing weekly versus three weekly schedules of cisplatinum concomitant with radical radiotherapy in locally advanced carcinoma uterine cervixGynecology Obstetrics201771
- BonomiPBlessingJAStehmanFBRandomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group StudyJ Clin Oncol19853810793894589
- ThigpenTShingletonHHomesleyHcis-Dichlorodiammineplatinum (II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology GroupCancer Treat Rep1979639–1015491555498154